Last reviewed · How we verify
Prevention of deep vein thrombosis
Approved treatments
- Dabigatran etexilate (DE) · Pfizer Inc.
Dabigatran etexilate (DE) as oral capsule - Xarelto · University Hospital, Montpellier
- Arixtra · Mylan Ireland Ltd
Arixtra works by blocking the action of factor Xa, a protein involved in blood clotting. - Heparin Sodium In Plastic Container · Merck & Co.
Heparin works by binding to Antithrombin-III, a protein that inhibits the formation of blood clots. - Savaysa · Daiichi Sankyo Inc
Savaysa works by blocking the action of coagulation factor X, a key protein involved in blood clotting. - Xarelto · Johnson & Johnson
Selective FXa inhibitor that decreases thrombin generation without requiring cofactors. - Pradaxa · Boehringer Ingelheim
Competitive direct thrombin inhibitor preventing fibrin formation and thrombus development. - Revasc · Marathon Pharms Llc
- Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa. - Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis. - Arixtra · LifeBridge Health
- Pradaxa · Generic (originally Boehringer Ingelheim)
Direct thrombin inhibitor that blocks both free and clot-bound thrombin, providing anticoagulation without routine monitoring.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of deep vein thrombosis patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of deep vein thrombosis treatment landscape brief
- Prevention of deep vein thrombosis treatment updates RSS
Frequently asked questions about Prevention of deep vein thrombosis
What drugs treat Prevention of deep vein thrombosis?
Tracked treatments include Dabigatran etexilate (DE), Xarelto, Arixtra, Heparin Sodium In Plastic Container, Savaysa, Pradaxa, Revasc, Coumadin.
What is the treatment for Prevention of deep vein thrombosis?
Standard treatment for Prevention of deep vein thrombosis includes Dabigatran etexilate (DE), Xarelto, Arixtra, Heparin Sodium In Plastic Container, Savaysa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of deep vein thrombosis patent cliff · Prevention of deep vein thrombosis CI report
- Treatment: Dabigatran etexilate (DE) · Pfizer Inc.
- Treatment: Xarelto · University Hospital, Montpellier
- Treatment: Arixtra · Mylan Ireland Ltd
- Treatment: Heparin Sodium In Plastic Container · Merck & Co.
- Treatment: Savaysa · Daiichi Sankyo Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing